Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2017 | Pages:
103 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Alzheimer's Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Alzheimer's Drugs in these regions, from 2012 to 2022 (forecast).
United States Alzheimer's Drugs market competition by top manufacturers/players, with Alzheimer's Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Johnson & Johnson
Novartis
Pfizer
Eisai Pharmaceuticals
Allergan
Amgen
Biogen
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Acetylcholinesterase (AChE) Inhibitors
Glutamate Inhibitors
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Alzheimer's Drugs for each application, including
Under 65 Years Old
65 and Above 65 Years Old
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Alzheimer's Drugs Market Report 2017
1 Alzheimer's Drugs Overview
1.1 Product Overview and Scope of Alzheimer's Drugs
1.2 Classification of Alzheimer's Drugs by Product Category
1.2.1 United States Alzheimer's Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Alzheimer's Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Acetylcholinesterase (AChE) Inhibitors
1.2.4 Glutamate Inhibitors
1.2.5 Other
1.3 United States Alzheimer's Drugs Market by Application/End Users
1.3.1 United States Alzheimer's Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Under 65 Years Old
1.3.3 65 and Above 65 Years Old
1.4 United States Alzheimer's Drugs Market by Region
1.4.1 United States Alzheimer's Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Alzheimer's Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Alzheimer's Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Alzheimer's Drugs Status and Prospect (2012-2022)
1.4.5 New England Alzheimer's Drugs Status and Prospect (2012-2022)
1.4.6 The South Alzheimer's Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Alzheimer's Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Alzheimer's Drugs (2012-2022)
1.5.1 United States Alzheimer's Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Alzheimer's Drugs Revenue and Growth Rate (2012-2022)
2 United States Alzheimer's Drugs Market Competition by Players/Suppliers
2.1 United States Alzheimer's Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Alzheimer's Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Alzheimer's Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Alzheimer's Drugs Market Competitive Situation and Trends
2.4.1 United States Alzheimer's Drugs Market Concentration Rate
2.4.2 United States Alzheimer's Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alzheimer's Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 United States Alzheimer's Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Alzheimer's Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Alzheimer's Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Alzheimer's Drugs Price by Region (2012-2017)
4 United States Alzheimer's Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Alzheimer's Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Alzheimer's Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Alzheimer's Drugs Price by Type (2012-2017)
4.4 United States Alzheimer's Drugs Sales Growth Rate by Type (2012-2017)
5 United States Alzheimer's Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Alzheimer's Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Alzheimer's Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Alzheimer's Drugs Players/Suppliers Profiles and Sales Data
6.1 Johnson & Johnson
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Alzheimer's Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Johnson & Johnson Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Alzheimer's Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.2 Alzheimer's Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Eisai Pharmaceuticals
6.4.2 Alzheimer's Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eisai Pharmaceuticals Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Allergan
6.5.2 Alzheimer's Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Allergan Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Amgen
6.6.2 Alzheimer's Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Amgen Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Biogen
6.7.2 Alzheimer's Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biogen Alzheimer's Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...
7 Alzheimer's Drugs Manufacturing Cost Analysis
7.1 Alzheimer's Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alzheimer's Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Alzheimer's Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alzheimer's Drugs Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Alzheimer's Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Alzheimer's Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Alzheimer's Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Alzheimer's Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Alzheimer's Drugs Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Alzheimer's Drugs
Figure United States Alzheimer's Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Alzheimer's Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Acetylcholinesterase (AChE) Inhibitors Product Picture
Figure Glutamate Inhibitors Product Picture
Figure Other Product Picture
Figure United States Alzheimer's Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Alzheimer's Drugs by Application in 2016
Figure Under 65 Years Old Examples
Table Key Downstream Customer in Under 65 Years Old
Figure 65 and Above 65 Years Old Examples
Table Key Downstream Customer in 65 and Above 65 Years Old
Figure United States Alzheimer's Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alzheimer's Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Alzheimer's Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alzheimer's Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Alzheimer's Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Alzheimer's Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alzheimer's Drugs Sales Share by Players/Suppliers
Figure 2017 United States Alzheimer's Drugs Sales Share by Players/Suppliers
Figure United States Alzheimer's Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Alzheimer's Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Alzheimer's Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alzheimer's Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Alzheimer's Drugs Revenue Share by Players/Suppliers
Table United States Market Alzheimer's Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Alzheimer's Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Alzheimer's Drugs Market Share of Top 3 Players/Suppliers
Figure United States Alzheimer's Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alzheimer's Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alzheimer's Drugs Product Category
Table United States Alzheimer's Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Alzheimer's Drugs Sales Share by Region (2012-2017)
Figure United States Alzheimer's Drugs Sales Share by Region (2012-2017)
Figure United States Alzheimer's Drugs Sales Market Share by Region in 2016
Table United States Alzheimer's Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Alzheimer's Drugs Revenue Share by Region (2012-2017)
Figure United States Alzheimer's Drugs Revenue Market Share by Region (2012-2017)
Figure United States Alzheimer's Drugs Revenue Market Share by Region in 2016
Table United States Alzheimer's Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Alzheimer's Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Alzheimer's Drugs Sales Share by Type (2012-2017)
Figure United States Alzheimer's Drugs Sales Share by Type (2012-2017)
Figure United States Alzheimer's Drugs Sales Market Share by Type in 2016
Table United States Alzheimer's Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Alzheimer's Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alzheimer's Drugs by Type (2012-2017)
Figure Revenue Market Share of Alzheimer's Drugs by Type in 2016
Table United States Alzheimer's Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Alzheimer's Drugs Sales Growth Rate by Type (2012-2017)
Table United States Alzheimer's Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Alzheimer's Drugs Sales Market Share by Application (2012-2017)
Figure United States Alzheimer's Drugs Sales Market Share by Application (2012-2017)
Figure United States Alzheimer's Drugs Sales Market Share by Application in 2016
Table United States Alzheimer's Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Alzheimer's Drugs Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Novartis Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Eisai Pharmaceuticals Basic Information List
Table Eisai Pharmaceuticals Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Pharmaceuticals Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Eisai Pharmaceuticals Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Eisai Pharmaceuticals Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Allergan Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Amgen Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Amgen Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Alzheimer's Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Alzheimer's Drugs Sales Growth Rate (2012-2017)
Figure Biogen Alzheimer's Drugs Sales Market Share in United States (2012-2017)
Figure Biogen Alzheimer's Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Drugs
Figure Manufacturing Process Analysis of Alzheimer's Drugs
Figure Alzheimer's Drugs Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Drugs Major Players/Suppliers in 2016
Table Major Buyers of Alzheimer's Drugs
Table Distributors/Traders List
Figure United States Alzheimer's Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer's Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer's Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Alzheimer's Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Alzheimer's Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alzheimer's Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
